Skip to Content
Creating memories for families by sharing information relating to children and parents with regard to activities, products, school, home and more.

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

Thu, 2010-07-29 02:05 — earnie

The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.



Theme by Dr. Radut.